patient safety quality healthcare

LATEST PATIENT SAFETY AND QUALITY HEALTHCARE NEWS

PSQH CAREER CENTER

CURRENT ISSUE

PSQH Twitter Feed

UPCOMING WEBINAR

An IC Check-Up

patient safety webinarPlease register for Strategies to Manage Hospital Acquired Conditions Reporting in an ACA World - An IC Check-Up on Sept 9th, 2014 1:00 PM CDT at: https://attendee.gotowebinar.com/register/5973501898406116610

With the August 1 Final Rule announcement by CMS, it’s time we had an Infection Control check-up from our IC expert, Brian Foy.

Brian will explain recent changes to Federal rules and its impacts on everyday IC preventionists. Then, the team will outline some of the experienced and expected challenges faced by industry partners and their solutions.

More information on Strategies to Manage Hospital Acquired Conditions Reporting in an ACA World - An IC Check-Up...

RECENT FEATURES & COLUMNS

ONLINE FIRST

MOST READ ARTICLES

PATIENT SAFETY AND QUALITY HEALTHCARE BLOG

FEATURED WHITE PAPER

Is the Answer to Enhanced Patient Safety Hiding in Plain Sight?
The Transformation of “Incident Reporting

Is the Answer to Enhanced Patient Safety Hiding in Plain Sight? The Transformation of “Incident ReportingWe all have these systems, whether paper or electronic, that are supposed to capture incidents that can lead to and/or have resulted in patient harm. Most of these systems can do this, but many will agree that there is something missing – something important – when it comes to whether or not these systems actually enhance patient safety.

We cannot just track incidents anymore; we need to make this an organization-wide process where we build awareness, which leads to intervention, and results in changes that can be seen and monitored. In this white paper, we discuss the transformation of traditional “incident reporting” into an integrated patient safety management system and offer a path to achieve this transformation.


Click here to download a free PDF.

More Patient Safety and Quality Healthcare White Papers...

patient safety news

Baxter International Inc. announced the company has completed its planned acquisition of Baxa Corporation, a privately held global company based in Englewood, Colo., for a cash consideration of $380 million. Baxa develops pharmacy technology that enhances the efficiency and safety of oral and IV dose preparation and delivery.
Deerfield, Illinois, November 10, 2011 - Baxter International Inc. announced the company has completed its planned acquisition of Baxa Corporation, a privately held global company based in Englewood, Colo., for a cash consideration of $380 million. Baxa develops pharmacy technology that enhances the efficiency and safety of oral and IV dose preparation and delivery.


"The acquisition of Baxa demonstrates Baxter's long-term commitment to nutrition and patient safety and it allows us to offer a broader range of solutions for the safe preparation and delivery of IV medications," said Robert M. Davis, president of Baxter's Medical Products business. "We believe Baxa's expertise in safely preparing IV and oral liquid medications, and their shared commitment toward improving patient care through innovative drug preparation and delivery technology will benefit patients around the world."

Among the product offerings now part of the Baxter portfolio are the ExactaMix® Compounder, devices that automate multi-ingredient solution compounding; ExactaMed® Syringes, dispensers that provide greater accuracy for dosing oral liquid medications; NeoThrive® Enteral Feeding System, enteral syringes and accessories; and the DoseEdge® Pharmacy Workflow Manager, an integrated system for managing IV and oral dose preparation activities.

Annual sales for Baxa were $157 million in 2010, and Baxter expects the top-line growth of this business to be accretive to the company's future sales growth. In addition, Baxter expects this transaction to be dilutive to 2012 earnings by $0.03 to $0.05 per diluted share primarily related to acquisition-accounting and transaction-related expenses. Excluding these items, the acquisition is neutral to full-year 2012 earnings and increasingly accretive thereafter.


About Baxter's Medical Products Business
Baxter's Medical Products business develops and provides products used in the delivery of fluids and drugs to patients. These include IV solutions and administration sets, premixed drugs and drug-reconstitution systems, IV nutrition products, infusion pumps, inhalation anesthetics and products and services for people with end-stage kidney disease. At the forefront of IV nutrition, Baxter's ongoing advancements include multi-chamber containers, lipids, amino acids, vitamins and admixing technology.

About Baxter

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

SPONSORS

ABQAURP American Society for Quality American Society for Quality Healthcare Division Consumers Advancing Patient Safety
EMPSF Institute for Safe Medical Practices
           
Medically Induced Trauma Support Services (MITSS) Medication Safety Officers Society NPSF Partnership for Patient Safety Society to Improve Diagnosis in Medicine